Correlation Between Nautilus Biotechnology and MAIA Biotechnology
Can any of the company-specific risk be diversified away by investing in both Nautilus Biotechnology and MAIA Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nautilus Biotechnology and MAIA Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nautilus Biotechnology and MAIA Biotechnology, you can compare the effects of market volatilities on Nautilus Biotechnology and MAIA Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nautilus Biotechnology with a short position of MAIA Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nautilus Biotechnology and MAIA Biotechnology.
Diversification Opportunities for Nautilus Biotechnology and MAIA Biotechnology
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Nautilus and MAIA is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Nautilus Biotechnology and MAIA Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MAIA Biotechnology and Nautilus Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nautilus Biotechnology are associated (or correlated) with MAIA Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MAIA Biotechnology has no effect on the direction of Nautilus Biotechnology i.e., Nautilus Biotechnology and MAIA Biotechnology go up and down completely randomly.
Pair Corralation between Nautilus Biotechnology and MAIA Biotechnology
Given the investment horizon of 90 days Nautilus Biotechnology is expected to generate 0.73 times more return on investment than MAIA Biotechnology. However, Nautilus Biotechnology is 1.36 times less risky than MAIA Biotechnology. It trades about -0.02 of its potential returns per unit of risk. MAIA Biotechnology is currently generating about -0.07 per unit of risk. If you would invest 264.00 in Nautilus Biotechnology on August 25, 2024 and sell it today you would lose (24.00) from holding Nautilus Biotechnology or give up 9.09% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nautilus Biotechnology vs. MAIA Biotechnology
Performance |
| Timeline |
| Nautilus Biotechnology |
| MAIA Biotechnology |
Nautilus Biotechnology and MAIA Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nautilus Biotechnology and MAIA Biotechnology
The main advantage of trading using opposite Nautilus Biotechnology and MAIA Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nautilus Biotechnology position performs unexpectedly, MAIA Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MAIA Biotechnology will offset losses from the drop in MAIA Biotechnology's long position.| Nautilus Biotechnology vs. C4 Therapeutics | Nautilus Biotechnology vs. Kymera Therapeutics | Nautilus Biotechnology vs. Foghorn Therapeutics | Nautilus Biotechnology vs. Revolution Medicines |
| MAIA Biotechnology vs. Lineage Cell Therapeutics | MAIA Biotechnology vs. Armata Pharmaceuticals | MAIA Biotechnology vs. Portage Biotech | MAIA Biotechnology vs. Larimar Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |